{"public_id":"cl_110360483889dccb19a24a6e945ffdd0","status":"active","superseded_by_public_id":null,"corpus_id":252967410,"text":"SARS-CoV-2 vaccination was associated with higher risk of myocarditis death in all age groups including the elderly, with a standardized mortality ratio of 2.01 (1.44 to 2.80) for the overall vaccinated population.","confidence":0.9,"paper":{"corpus_id":252967410,"title":"SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan","url":"https://sah.borca.ai/papers/252967410"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0eae4b7c310863fc59df49dfe9f896cd","name":"SARS-CoV-2 vaccination","description":"Receipt of one or two doses of SARS-CoV-2 vaccine among individuals aged 12 years and older in Japan by 14 February 2022.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_0eae4b7c310863fc59df49dfe9f896cd"},{"public_id":"co_2f3cd1d613ae7062501e585d30ff4f27","name":"myocarditis death","description":"Death with 'myocarditis' listed as cause of death and with onset within 28 days after vaccination, disclosed on 5 August 2022.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_2f3cd1d613ae7062501e585d30ff4f27"},{"public_id":"co_6c51c9cf48445be7f304982ba2143a0c","name":"standardized mortality ratio","description":"Ratio of observed myocarditis deaths in the vaccinated population to expected deaths based on the reference population, calculated for overall and age-stratified groups.","types":["metric"],"url":"https://sah.borca.ai/concepts/co_6c51c9cf48445be7f304982ba2143a0c"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_110360483889dccb19a24a6e945ffdd0"}